Interventional Treatment of Residual Pulmonary Hypertension in Patients After Pulmonary Thromboen… (NCT02745106) | Clinical Trial Compass
UnknownPhase 2
Interventional Treatment of Residual Pulmonary Hypertension in Patients After Pulmonary Thromboendarterectomy
Russia50 participantsStarted 2015-08
Plain-language summary
The study evaluates the technique of non-drug treatment of residual pulmonary hypertension in patients with chronic thromboembolic pulmonary hypertension after pulmonary thromboendarterectomy.
Who can participate
Age range18 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* presence of residual pulmonary hypertension in patients after pulmonary thromboendarterectomy according to right heart catheterization: mean pulmonary artery pressure \> 25 mm Hg or pulmonary vascular resistance \> 400 dyn x sec x cm-5
Exclusion Criteria:
* no evidence of residual pulmonary hypertension in patients after pulmonary thromboendarterectomy (mean pulmonary artery pressure \<25 m Hg).
* refusal of a patient to participate in the study.
* the presence of severe concomitant diseases of the cardiovascular system and lungs, leading to pulmonary hypertension
* the presence of other severe comorbidities that may result in death within a year.
What they're measuring
1
Pulmonary vascular resistance
Timeframe: 12 months
Trial details
NCT IDNCT02745106
SponsorNovosibirsk Scientific Research Institute for Circulatory Pathology